The store will not work correctly when cookies are disabled.
3-ethyl-5-(3-(hydroxycarbamoyl)-2-(hydroxymethyl)pentyl)-1-methyl-1H-imidazol-3-ium Iodide
ID: ALA3275311
PubChem CID: 90679003
Max Phase: Preclinical
Molecular Formula: C13H24IN3O3
Molecular Weight: 270.35
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCC(C(=O)NO)C(CO)Cc1c[n+](CC)cn1C.[I-]
Standard InChI: InChI=1S/C13H23N3O3.HI/c1-4-12(13(18)14-19)10(8-17)6-11-7-16(5-2)9-15(11)3;/h7,9-10,12,17H,4-6,8H2,1-3H3,(H-,14,18,19);1H
Standard InChI Key: CYNKGZKVADDQRG-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 19 0 0 0 0 0 0 0 0999 V2000
29.8473 -23.9839 0.0000 I 0 0 0 0 0 0 0 0 0 0 0 0
27.7349 -24.6644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5521 -24.6644 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.8065 -23.8876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1435 -23.4055 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.4848 -23.8876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7075 -23.6355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1004 -24.1825 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0317 -25.3260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6984 -26.0722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1423 -22.5883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3231 -23.9304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2707 -24.9818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6637 -25.5289 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.7161 -24.4774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9388 -24.2253 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.8864 -25.2767 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.1529 -23.1311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7599 -22.5840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3317 -24.7724 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 1 0
6 2 2 0
6 7 1 0
7 8 1 0
3 9 1 0
9 10 1 0
5 11 1 0
8 12 1 0
8 13 1 0
13 14 1 0
12 15 1 0
15 16 1 0
15 17 2 0
12 18 1 0
18 19 1 0
16 20 1 0
M CHG 2 1 -1 3 1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 270.35 | Molecular Weight (Monoisotopic): 270.1812 | AlogP: 0.02 | #Rotatable Bonds: 7 |
Polar Surface Area: 78.37 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.87 | CX Basic pKa: ┄ | CX LogP: -3.72 | CX LogD: -3.73 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.37 | Np Likeness Score: 0.56 |
References
1. Ben-Bassat AA, Lavie D.. (1976) Quaternary pilocarpine derivatives as potential acetylcholine antagonists. 2. Alterations in the lactone and imidazole moieties., 19 (7): [PMID:940111] [10.1021/jm00229a014] |